Management of Hepatotoxicity Induced by the Use of Olanzapine

Basit Öğe Kaydı
dc.authoridDönmez, Yunus Emre/0000-0002-7785-2805
dc.authoridÖzcan, Özlem/0000-0003-3267-2648
dc.authorwosidDönmez, Yunus Emre/O-6102-2015
dc.authorwosidDönmez, Yunus Emre/AAV-9952-2021
dc.authorwosidSoylu, Nusret/AAT-6501-2020
dc.authorwosidÖzcan, Özlem/ABH-9167-2020
dc.contributor.authorDonmez, Yunus Emre
dc.contributor.authorOzcan, Ozlem
dc.contributor.authorSoylu, Nusret
dc.contributor.authorSarioglu, Fatma Kartal
dc.contributor.authorSelimoglu, Ayse
dc.date.accessioned2024-08-04T20:43:09Z
dc.date.available2024-08-04T20:43:09Z
dc.date.issued2017
dc.departmentİnönü Üniversitesien_US
dc.description.abstractNumerous drugs cause hepatotoxicity clinically or biologically. Neuropsychiatric drugs constitute 16% of these drugs. The occurrence of hepatotoxicity induced by the use of olanzapine is expressed by the researchers. In such cases, generally the dose of olanzapine is reduced or the drug is completely discontinued and the treatment of the patient fails. The aim of this study is to report the case for whom elevated liver enzymes were observed but the process was managed without changing treatment dose and drug and to discuss this case with literature information. The present study has characteristics of being the first in the literature concerning management of the process.en_US
dc.identifier.doi10.1089/cap.2016.0178
dc.identifier.endpage294en_US
dc.identifier.issn1044-5463
dc.identifier.issn1557-8992
dc.identifier.issue3en_US
dc.identifier.pmid28398814en_US
dc.identifier.scopus2-s2.0-85018545336en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage293en_US
dc.identifier.urihttps://doi.org/10.1089/cap.2016.0178
dc.identifier.urihttps://hdl.handle.net/11616/97796
dc.identifier.volume27en_US
dc.identifier.wosWOS:000399535900014en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherMary Ann Liebert, Incen_US
dc.relation.ispartofJournal of Child and Adolescent Psychopharmacologyen_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectatypical antipsychoticsen_US
dc.subjecthepatotoxicityen_US
dc.subjectliver enzymesen_US
dc.subjectolanzapineen_US
dc.subjectside effectsen_US
dc.titleManagement of Hepatotoxicity Induced by the Use of Olanzapineen_US
dc.typeLetteren_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu